Company Filing History:
Years Active: 2009-2012
Title: The Innovations of Kerstin Leuther
Introduction
Kerstin Leuther is a notable inventor based in San Jose, California. She has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that target the erythropoietin receptor.
Latest Patents
Kerstin Leuther holds four patents, with her latest inventions focusing on erythropoietin receptor peptide formulations and their therapeutic uses. These peptide compounds act as agonists of the erythropoietin receptor (EPO-R) and are designed to treat disorders related to insufficient or defective red blood cell production. The patents also include pharmaceutical compositions that incorporate these peptide compounds, along with specified dosages for effective treatment.
Career Highlights
Kerstin is currently employed at Affymax, Inc., where she continues to innovate in the field of biotechnology. Her work has been instrumental in advancing therapeutic methods that address critical health issues.
Collaborations
Kerstin collaborates with esteemed colleagues such as Anne-Marie Duliege and Richard Stead, contributing to a dynamic research environment that fosters innovation.
Conclusion
Kerstin Leuther's work exemplifies the impact of innovative thinking in biotechnology. Her patents and ongoing research are paving the way for new therapeutic solutions in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.